Consensus for FY23 EPS is $2.90. Lowers FY23 revenue view to $17.9B-$18.2B from $18.6B-$18.9B, consensus $18.54B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CTVA:
- Corteva Reports Second Quarter and First Half 2023 Results, Updates Full-Year Net Sales and Earnings Guidance
- Corteva increases quarterly dividend 7% to 16c per share
- Corteva Announces Increased Quarterly Dividend
- Evogene price target raised to $6 from $1 at Roth MKM
- Corteva price target lowered to $74 from $76 at Mizuho